New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence

Xu, Jianrong; Yang, Zhuo; Ma, Shuren; Jia, Wen; Zhao, Qian; Xu, Lan; Kan, Ying; Cao, Yang; Wang, Yao; Fan, Bao-Jun

doi:10.4240/wjgs.v14.i3.236

Cited by 5 publications

(12 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Figure 1 shows the PRISMA diagram for the study selection and inclusion process. A total of 37 studies with 12,952 patients were included in the final analysis 1–6,11–41 . Table 1 shows the baseline characteristics of the studies included in the present meta‐analysis, along with the study quality assessment.…”

Section: Resultsmentioning

confidence: 99%

“…Overall, 35 studies ( n = 11,771) reported the recurrence of CBD stones after initial clearance with ERCP 1–6,11–27,29–41 . The pooled event rate for the recurrence of CBD stones was 12.6% (95% confidence interval [CI]: 11.2–13.9; I 2 = 79.2%).…”

Section: Resultsmentioning

confidence: 99%

“…The most important risk factor was a CBD diameter ≥ 15 mm, which had a significant association with recurrence in 12 studies. 1,2,13,21,23,25,[29][30][31][32]38,39 Other risk factors with significant association with recurrence in three or more studies were reduced angulation of the bile duct (seven studies), 5,14,17,27,30,31,37 the presence of periampullary diverticulum (seven…”

Section: F I G U R Ementioning

confidence: 99%

See 2 more Smart Citations

Recurrence of common bile duct stones after endoscopic clearance and its predictors: A systematic review

Kozyk,

Giri,

Harindranath

et al. 2023

DEN Open

View full text Add to dashboard Cite

BackgroundThe primary therapeutic strategy for the management of bile duct stones (BDS) is endoscopic retrograde cholangiopancreatography. However, there may be a recurrence of BDS on follow‐up. Multiple risk factors have been studied for the prediction of BDS recurrence. We aimed to analyze the incidence of symptomatic BDS recurrence, systematically review the risk factors, and analyze the most important risk factors among those.MethodsA comprehensive search of three databases was conducted from inception to November 2022 for studies reporting the recurrence of BDS recurrence after endoscopic retrograde cholangiopancreatography with clearance, along with an analysis of risk factors.ResultsA total of 37 studies with 12,952 patients were included in the final analysis. The pooled event rate for the recurrence of BDS stones was 12.6% (95% confidence interval: 11.2–13.9). The most important risk factor was a bile duct diameter ≥15 mm, which had a significant association with recurrence in twelve studies. Other risk factors with significant association with recurrence in three or more studies were the reduced angulation of the bile duct, the presence of periampullary diverticulum, type I periampullary diverticulum, in‐situ gallbladder with stones, cholecystectomy, multiple stones in the bile duct, use of mechanical lithotripsy, and bile duct stent placement.ConclusionAround one out of seven patients have BDS recurrence after the initial endoscopic retrograde cholangiopancreatography. Bile duct size and anatomy are the most important predictors of recurrence. The assessment of risk factors associated with recurrence may help keep a close follow‐up in high‐risk patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: F I G U R Ementioning

confidence: 99%

See 1 more Smart Citation

Recurrence of common bile duct stones after endoscopic clearance and its predictors: A systematic review

Kozyk,

Giri,

Harindranath

et al. 2023

DEN Open

View full text Add to dashboard Cite

show abstract

“…Thus, ESBD may be superior to EST in overall efficacy and short- and long-term complications, and ESBD may be recommended over EST in the future; however, there is insufficient evidence to recommend ESBD over EST. Therefore, to justify updating the current guidelines, researchers will require more evidence that ESBD is superior to EST in terms of overall efficacy[ 20 ] and that ESBD may reduce the long-term recurrence rate of bile duct stones[ 33 ]. At this time, it is up to each endoscopist to decide whether to perform ESBD or EST.…”

Section: Comparison Of Epbd and Estmentioning

confidence: 99%

Comprehensive review on small common bile duct stones

Masuda¹,

Koizumi²,

Shionoya³

et al. 2023

World J Gastroenterol

View full text Add to dashboard Cite

Common bile duct stones are among the most common conditions encountered by endoscopists. Therefore, it is well researched; however, some items, such as indications for endoscopic papillary balloon dilatation (EPBD), safety of EPBD and endoscopic sphincterotomy in patients receiving dual antiplatelet therapy or direct oral anticoagulant, selection strategy for retrieval balloons and baskets, lack adequate evidence. Therefore, the guidelines have been updated with new research, while others remain unchanged due to weak evidence. In this review, we comprehensively summarize the standard methods in guidelines and new findings from recent studies on papillary dilation, stone retrieval devices, difficult-to-treat cases, troubleshooting during the procedure, and complicated cases of cholangitis, cholecystolithiasis, or distal biliary stricture.

show abstract

“…We read with interest the retrospective cohort study by Ji et al [ 1 ]. In their study, the authors presented that the morphologies of the common bile duct (CBD), especially the S and polyline types, were associated with increased recurrence of CBD stones.…”

Section: To the Editormentioning

confidence: 99%

Risk prediction of common bile duct stone recurrence based on new common bile duct morphological subtypes

Saito¹,

Tada²

2022

WJGS

View full text Add to dashboard Cite

Stones in the common bile duct (CBD) are reported worldwide, and this condition is majorly managed through endoscopic retrograde cholangiopancreatography (ERCP). CBD stone recurrence is an important issue after endoscopic stone removal. Therefore, it is essential to identify its risk factors to determine the necessity of regular follow-up in patients who underwent endoscopic removal of CBD stones. The authors identified that the S and polyline morphological subtypes of CBD were associated with increased stone recurrence. New morphological subtypes of CBD presented by the authors can be important risk predictors of recurrence after endoscopic stone removal. Furthermore, the new morphological subtypes of CBD may predict the risk of residual CBD stones or technical difficulty in CBD stone removal. Further studies with a large sample size and longer follow-up durations are warranted to examine the usefulness of the newly identified morphological subtypes of CBD in predicting the outcomes of ERCP for CBD stone removal.

show abstract

New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence

Cited by 5 publications

References 51 publications

Recurrence of common bile duct stones after endoscopic clearance and its predictors: A systematic review

Recurrence of common bile duct stones after endoscopic clearance and its predictors: A systematic review

Comprehensive review on small common bile duct stones

Risk prediction of common bile duct stone recurrence based on new common bile duct morphological subtypes

Contact Info

Product

Resources

About